ArticlePharmaceuticals (Basel, Switzerland)2025

Unveiling the Polypharmacological Potency of FDA-Approved Rebamipide for Alzheimer's Disease.

Israa J Hakeem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.